Dynamic Medical Technologies (4138) — Capital Reinvestment Ratio
Dynamic Medical Technologies (4138) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$246.38 Million) in capital expenditures (NT$3.73 Million). See 4138 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dynamic Medical Technologies Capital Reinvestment Ratio (2016–2025)
This chart tracks Dynamic Medical Technologies's Capital Reinvestment Ratio across 10 annual periods. Check 4138 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dynamic Medical Technologies (2016–2025)
Year-by-year Capital Reinvestment Ratio for Dynamic Medical Technologies from 2016 to 2025. For live market cap and broader valuation context, see Dynamic Medical Technologies market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | NT$314.86 Million | NT$52.15 Million | ▼ -62.0% |
| 2024 | 0.44x | NT$224.11 Million | NT$97.58 Million | ▲ +118.9% |
| 2023 | 0.20x | NT$360.95 Million | NT$71.80 Million | ▼ -52.0% |
| 2022 | 0.41x | NT$276.93 Million | NT$114.71 Million | ▲ +171.8% |
| 2021 | 0.15x | NT$277.64 Million | NT$42.31 Million | ▲ +334.3% |
| 2020 | 0.04x | NT$248.55 Million | NT$8.72 Million | ▼ -70.6% |
| 2019 | 0.12x | NT$274.48 Million | NT$32.80 Million | ▲ +10.5% |
| 2018 | 0.11x | NT$147.46 Million | NT$15.96 Million | ▼ -38.3% |
| 2017 | 0.18x | NT$145.18 Million | NT$25.46 Million | ▲ +172.7% |
| 2016 | 0.06x | NT$250.35 Million | NT$16.10 Million | — |